Agios second shot at sickle cell disease falls short on July 22, 2026 Agios Pharmaceuticals Anemia, Sickle Cell Decision development aspects discontinued mitapivat PK activator PYRUKYND tebapivat United States Food and Drug Administration +
Ousted ACIP Members Criticize RFK Jr.'s 'Destabilizing' Changes to U.S. Vaccine Policy on June 18, 2025 ACIP CDC Centers for Disease Control and Prevention (U.S.) Committee Decision Employment Termination Policy public health medicine (field) Recommendation RFK Jr. Vaccines +
Novo eyes fourth-quarter FDA verdict for oral Wegovy filing on May 06, 2025 Decision Novo Obesity Oral cavity Overweight semaglutide United States Food and Drug Administration Wegovy +
FDA decision on Stealth's Barth syndrome drug delayed, again on April 30, 2025 3-Methylglutaconic aciduria type 2 Decision Elamipretide United States Food and Drug Administration +
FDA to Decide on Merck's Subcutaneous Keytruda in September 2025 on March 28, 2025 2025 Cancer Therapeutic Procedure Co. Decision Merck & Co. PDUFA September 23 Subcutaneous Keytruda United States Food and Drug Administration +
Australia steadfast on rejection of Eisai, Biogen's Alzheimer's therapy Leqembi on March 04, 2025 Alzheimer 's disease Australia Decision Eisai Lecanemab Leqembi Presenile dementia +